Close follow-up is therefore essential, as combined immunosuppressive agents increase the risk of serious opportunistic infections. Approximately 22% of patients with JIA will require major surgical intervention during their lifetime . arthritis /th th align=”left” rowspan=”1″ colspan=”1″ Definitions /th /thead Systemic arthritisArthritis in one or more joints with or preceded by fever??2 weeks’ duration and accompanied by one or more of the following: br / (1) Evansecent (nonfixed) erythematous rash br / (2) Generalized lymph node enlargement br / (3) Hepatomegaly and/or splenomegaly br / (4) Serositis hr / Psoriatic arthritisArthritis and psoriasis or arthritis and 2 of the following: br / (1) Dactylitis br / (2) Nail and pitting or onycholysis br / (3) Psoriasis in a first-degree relative hr / Enthesitis-related arthritisArthritis and enthesitis or arthritis or enthesitis with 2 of the following: br / (1) Presence of or a history of sacroiliac joint tenderness and/or inflammatory lumbosacral pain br / (2) Presence of HLA-B27 antigen br / (3) Onset of arthritis in a male 6 years of age br / (4) Acute (symptomatic) anterior uveitis br / (5) History of ankylosing spondylitis, enthesitis-related arthritis, sacroiliitis with inflammatory bowel disease, Reiter’s syndrome, or acute anterior uveitis in a first-degree relative hr / OligoarticularArthritis affecting 1-4 joints during the first 6 months of disease. Two subcategories: br / Persistent oligoarthritis: affecting 4 joints throughout the disease course br / Extended oligoarthritis: affecting 4 joints after the first 6 months of disease hr / PolyarthritisRheumatoid factor negative: arthritis affecting 5 joints during the first 6 months of disease; RF test is negative br / Rheumatoid factor positive: arthritis affecting 5 joints during the first 6 months of disease; 2 or more tests for RF at least 3 months apart during the first 6 months of disease are positive hr / Undifferentiated arthritisArthritis that fulfills criteria in no category or in 2 or more of the above categories Open in a separate window While specific pathophysiologic processes of JIA categories may differ, T-cell-mediated destruction of joint spaces leading to a significant loss of function, pain, stiffness, fatigue, joint effusion, reduced cIAP1 Ligand-Linker Conjugates 2 range of motion, erythema, and growth alterations is the prevailing cause of morbidity in these patients [3, 4]. Impacted joints of serious consequence are the knee, hip, and temporomandibular joint and may require surgical intervention [5, 6]. Hip involvement in those with JIA is reported between 20%-40%, and early identification of hip involvement in these patients may lead to more aggressive early treatment before hip joint destruction occurs . However, cIAP1 Ligand-Linker Conjugates 2 when it does occur at a young age, it becomes challenging to treat and manage. Here, we present a case of a 10-year-old Mexican female who cIAP1 Ligand-Linker Conjugates 2 developed destructive bilateral hip disease in the setting of untreated Persistent Oligoarticular JIA. 1.1. Case Presentation The patient was initially presented cIAP1 Ligand-Linker Conjugates 2 to our clinic at the age of 9 with a chief complaint of limping. Her developmental history was notable for developmental delay without underlying genetic or autoimmune conditions and low infantile weight for which she had a gastric tube. Family history was negative for any neuromuscular disease, hip dysplasia, or autoimmune disease. She had recently moved from Mexico with her family to the United States. Her initial exam revealed a Trendelenburg gait and sign, left hip pain-free range-of-motion with 100 internal rotation, 50 external rotation, 135 flexion, 20 extension, and 70 abduction. Her right hip revealed pain-free range-of-motion with 90 internal rotation, 50 external rotation, 135 flexion, and 60 abduction. The comparison of both hips revealed a positive Galeazzi sign with a leg-length difference of 2 cm and normal bilateral reflexes. Imaging demonstrated bilateral hip dysplasia with left hip dislocation with pseudoacetabuli (Figures ?(Figures11 and ?and2).2). At this time, the working diagnosis was untreated bilateral hip dysplasia, and we discussed surgical options including fusion, pelvic and femoral osteotomies, and total hip arthroplasty (THA). Given the chronicity of her dislocation and severity of her dysplasia, it was determined that any surgical treatment on the unilateral left hip dislocation was unlikely to provide a significant benefit and may make her worse. We recommended proceeding with a possible THA versus fusion in her teenage years when pain warranted treatment. For the right cIAP1 Ligand-Linker Conjugates 2 hip, we recommended a future periacetabular osteotomy (PAO) once her triradiate cartilage closed and her hip became symptomatic, possibly in a few years. Open in a separate FzE3 window Figure 1 Plain AP radiograph performed in April.